TY - JOUR
T1 - Parkinson's disease
T2 - Cause factors, measurable indicators, and early diagnosis
AU - Bhat, Shreya
AU - Acharya, U. Rajendra
AU - Hagiwara, Yuki
AU - Dadmehr, Nahid
AU - Adeli, Hojjat
PY - 2018/11/1
Y1 - 2018/11/1
N2 - Parkinson's disease (PD) is a neurodegenerative disease of the central nervous system caused due to the loss of dopaminergic neurons. It is classified under movement disorder as patients with PD present with tremor, rigidity, postural changes, and a decrease in spontaneous movements. Comorbidities including anxiety, depression, fatigue, and sleep disorders are observed prior to the diagnosis of PD. Gene mutations, exposure to toxic substances, and aging are considered as the causative factors of PD even though its genesis is unknown. This paper reviews PD etiologies, progression, and in particular measurable indicators of PD such as neuroimaging and electrophysiology modalities. In addition to gene therapy, neuroprotective, pharmacological, and neural transplantation treatments, researchers are actively aiming at identifying biological markers of PD with the goal of early diagnosis. Neuroimaging modalities used together with advanced machine learning techniques offer a promising path for the early detection and intervention in PD patients.
AB - Parkinson's disease (PD) is a neurodegenerative disease of the central nervous system caused due to the loss of dopaminergic neurons. It is classified under movement disorder as patients with PD present with tremor, rigidity, postural changes, and a decrease in spontaneous movements. Comorbidities including anxiety, depression, fatigue, and sleep disorders are observed prior to the diagnosis of PD. Gene mutations, exposure to toxic substances, and aging are considered as the causative factors of PD even though its genesis is unknown. This paper reviews PD etiologies, progression, and in particular measurable indicators of PD such as neuroimaging and electrophysiology modalities. In addition to gene therapy, neuroprotective, pharmacological, and neural transplantation treatments, researchers are actively aiming at identifying biological markers of PD with the goal of early diagnosis. Neuroimaging modalities used together with advanced machine learning techniques offer a promising path for the early detection and intervention in PD patients.
UR - http://www.scopus.com/inward/record.url?scp=85053819288&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85053819288&partnerID=8YFLogxK
U2 - 10.1016/j.compbiomed.2018.09.008
DO - 10.1016/j.compbiomed.2018.09.008
M3 - Review article
C2 - 30253869
AN - SCOPUS:85053819288
SN - 0010-4825
VL - 102
SP - 234
EP - 241
JO - Computers in Biology and Medicine
JF - Computers in Biology and Medicine
ER -